This article originally appeared on MyCentralJersey.com: Global pharmaceutical firm chooses Bridgewater for new corporate ...

Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry that look like strong buys right now: Pfizer (NYSE: PFE) and Eli Lilly (NYSE ...

You could make a strong argument that it's the expansion of so-called GLP-1 medications. These miracle drugs effectively promote weight loss (in addition to treating diabetes), but there's growing ...

BioMarin Pharmaceutical ( BMRN +1.56%) reported its third-quarter earnings after market close Monday, and they were good enough to push the biotech stock almost 2% higher the following day. With that ...

Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...

Development follows company’s ₹350-crore investment in India to expand research, manufacturing, and sustainability-led ...

ONO Pharmaceutical Co ( (JP:4528) ) has issued an update. ONO Pharmaceutical Co., Ltd. reported a 7% increase in revenue for the second quarter of FY 2025, compared to the same period last year, ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Key Points Added 4,306,363 Teva shares, an estimated $75.64 million trade based on the average quarterly price for Q3 2025 Transaction represents a 0.68% increase in reportable U.S. equity assets ...

Besides the pharmaceutical industry, the Holy Father also criticized the influence of big tech in promoting unhealthy, ...